A study on Diabetes Mellitus patients for checking Kidney function.
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2021/07/034834
- Lead Sponsor
- Mankind Pharma Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Male or female patients, age � 18 to � 85 years.
2. Uncontrolled Type 2 diabetes with a haemoglobin A1c (HbA1c) �7.0 percent.
3. eGFR (MDRD) at screening > 60 mL/min/1.73m2
4. Patients who are prescribed Teneligliptin and Metformin combination therapy as part of routine clinical practice.
1. Female patients who are pregnant or breast feeding
2. Patients with known liver or kidney dysfunction
3. Patients who are suspected of or known to have an intolerance to Teneligliptin or Metformin.
4. Presence of any other clinically significant disease or laboratory findings that in the Investigators opinion may affect the study outcomes or continued participation of patient in the study.
5. Participation in another study concurrently or within 4 weeks prior to the Screening Visit
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method